Browsing Category
Pharma Industry News
4724 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
The rare disease opportunity behind BridgeBio Pharma’s BBP-418 breakthrough (NASDAQ: BBIO)
BridgeBio Pharma advances BBP-418 after Phase 3 muscular dystrophy results. Could the therapy unlock a major rare disease opportunity? Read the full analysis.
Why YolTech Therapeutics believes YOLT-202 could become a “one-and-done” treatment for Alpha-1 Antitrypsin Deficiency
YolTech Therapeutics receives FDA clearance to launch a Phase 2/3 trial of YOLT-202 for Alpha-1 Antitrypsin Deficiency. Discover what this means for gene editing.
Why the EMA review of PolTREG-T1D could influence autoimmune cell therapy development
PolTREG-T1D moves toward European Medicines Agency review. Discover how this TREG cell therapy could reshape treatment for autoimmune diseases.
How Kaneka Corporation’s partnership with Toro Neurovascular could reshape U.S. commercialization of neurovascular catheters
Toro Neurovascular wins FDA clearance for the Toro 88 catheter. Discover how Kaneka Corporation’s partnership could reshape the U.S. neurovascular device market.
VERAXA Biotech clears final shareholder hurdle as Voyager Acquisition votes yes on $1.35bn oncology de-SPAC
Voyager Acquisition shareholders approve VERAXA Biotech combination. The cancer ADC and TCE platform heads to NASDAQ as VRXA. Read the full analysis.
What the LYMPHIR–pembrolizumab combination signals for the future of immunotherapy resistance (NASDAQ: CTOR)
Citius Oncology reports LYMPHIR immunotherapy data in gynecologic cancers. Discover what the trial signals for the future of cancer immunotherapy.
Can acoustic tomography compete with mammography and MRI in dense breast screening for QT Imaging Holdings Inc. (NASDAQ: QTI)?
QT Imaging Holdings Inc. wins FDA clearance for Breast Acoustic CT upgrade. Discover what it means for radiation-free breast imaging and dense breast screening.
The $9bn concussion treatment question Oragenics hopes ONP-002 can answer
Oragenics launches Phase IIa trial of ONP-002 for concussion. Discover whether this therapy could unlock the $9B traumatic brain injury market.
How JFCRx is expanding pharmacy automation with TruCard Stack to scale blister card production
JFCRx unveils TruCard Stack to automate blister card packaging and scale pharmacy workflows. Discover why adherence packaging automation is accelerating.
FUJIFILM Biotechnologies names former Rentschler Biopharma COO as Chief Business Officer ahead of global capacity ramp
FUJIFILM Biotechnologies appoints Christiane Bardroff as CBO from June 2026. What her hire signals for the CDMO's eight billion dollar capacity push. Read more.